CBS 2019
CBSMD教育中心
中 文

Transcatheter Aortic Valve Replacement

Abstract

Recommended Article

Incidence and Outcomes of Surgical Bailout During TAVR : Insights From the STS/ACC TVT Registry 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients Precision Medicine in TAVR: How to Select the Right Device for the Right Patient Aortic Valve Stenosis Treatment Disparities in the Underserved JACC Council Perspectives Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis Poor Long-Term Survival in Patients With Moderate Aortic Stenosis Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial

Clinical Trial2015 May 26;65(20):2184-94.

JOURNAL:J Am Coll Cardiol. Article Link

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial

Thyregod HG, Steinbrüchel DA, Ihlemann N et al. Keywords: severe aortic valve stenosis; low-risk patients; self-expanding bioprosthesis; TAVI; SAVR; 1-year outcome

FULL TEXT PDF